Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes

References

• Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience. Cancer 1998;82:1062–70.
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685–92.
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:348–53.
   PubMed Web of Science ®Google Scholar
• Park KJ, Chung JY, Chun MS, Suh JH. Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000;20:83–98.
   PubMed Web of Science ®Google Scholar
• Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis?A systematic review of the literature. Radiother Oncol 2012;102:335–42.
   PubMed Web of Science ®Google Scholar
• Takeda A, Kunieda E, Takeda T, Tanaka M, Sanuki N, Fujii H, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70:1057–65.
   PubMed Web of Science ®Google Scholar
• Neri S, Takahashi Y, Terashi T, Hamakawa H, Tomii K, Katakami N, et al. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J Thorac Oncol 2010;5:2003–7.
   PubMed Web of Science ®Google Scholar
• Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 2007;56:229–34.
   PubMed Web of Science ®Google Scholar
• Laurent F, Montaudon M, Latrabe V, Begueret H. Percutaneous biopsy in lung cancer. Eur J Radiol 2003;45: 60–8.
   PubMed Web of Science ®Google Scholar
• Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J Clin Oncol 2010;28:5153–9.
   PubMed Web of Science ®Google Scholar
• Partridge M, Yamamoto T, Grau C, Hoyer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997–1011.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
   PubMed Web of Science ®Google Scholar
• Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 2011;6:1221–8.
   PubMed Web of Science ®Google Scholar
• Palma DA, van Sornsen de Koste J, Verbakel WF, Vincent A, Senan S. Lung density changes after stereotactic radiotherapy: A quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys 2011;81:974–8.
   PubMed Web of Science ®Google Scholar
• Palma DA, Senan S, Haasbeek CJ, Verbakel WF, Vincent A, Lagerwaard F. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: A matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys 2011;80: 506–13.
   PubMed Web of Science ®Google Scholar
• Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 2006;31:1116–28.
   PubMed Web of Science ®Google Scholar
• Takeda T, Takeda A, Kunieda E, Ishizaka A, Takemasa K, Shimada K, et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: Serial changes on CT. AJR Am J Roentgenol 2004;182: 1123–8.
   PubMed Web of Science ®Google Scholar
• Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008;246:697–722.
   PubMed Web of Science ®Google Scholar
• Louie AV, Rodrigues G, Olsthoorn J, Palma D, Yu E, Yaremko B, et al. Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era. Radiother Oncol 2010;95:166–71.
   PubMed Web of Science ®Google Scholar
• Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: An epidemiologic inquiry. J Natl Cancer Inst 1984;72:1271–5.
   PubMed Web of Science ®Google Scholar
• Kato S, Nambu A, Onishi H, Saito A, Kuriyama K, Komiyama T, et al. Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Jpn J Radiol 2010;28: 259–65.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Nagata Y, Mizowaki T, Takayama K, Sakamoto T, Sakamoto M, et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007;12:356–62.
   PubMed Web of Science ®Google Scholar
• Lamers RJ, Kemerink GJ, Drent M, van Engelshoven JM. Reproducibility of spirometrically controlled CT lung densitometry in a clinical setting. Eur Respir J 1998;11: 942–5.
   PubMed Web of Science ®Google Scholar
• Palma DA, van Sornsen de Koste JR, Verbakel WF, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50: 509–17.
   PubMed Web of Science ®Google Scholar